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Abstract. 
 
The coiled body is a distinct subnuclear do-
main enriched in small nuclear ribonucleoprotein parti-
cles (snRNPs) involved in processing of pre-mRNA. 
Although the function of the coiled body is still un-
known, current models propose that it may have a role 
in snRNP biogenesis, transport, or recycling. Here we 
describe that anti-coilin antibodies promote a specific 
disappearance of the coiled body in living human cells, 
thus providing a novel tool for the functional analysis of 
this structure. Monoclonal antibodies (mAbs) were 
raised against recombinant human coilin, the major 
structural protein of the coiled body. Four mAbs are 
shown to induce a progressive disappearance of coiled 
 
bodies within 
 
z
 
6 h after microinjection into the nucleus 
of HeLa cells. After their disappearance, coiled bodies 
are not seen to re-form, although injected cells remain 
viable for at least 3 d. Epitope mapping reveals that the 
mAbs recognize distinct amino acid motifs scattered 
along the complete coilin sequence. By 24 and 48 h af-
ter injection of antibodies that promote coiled body dis-
appearance, splicing snRNPs are normally distributed 
in the nucleoplasm, the nucleolus remains unaffected, 
and the cell cycle progresses normally. Furthermore, 
cells devoid of coiled bodies for 
 
z
 
24 h maintain the 
ability to splice both adenoviral pre-mRNAs and tran-
 
siently overexpressed human 
 
b
 
-globin transcripts. In 
conclusion, within the time range of this study, no ma-
jor nuclear abnormalities are detected after coiled body 
disappearance.
Key words: coiled body • p80–coilin • splicing • splice-
osomal snRNPs • nucleolus
 
he 
 
intranuclear structure that is now known as the
coiled body was first described in 1903 by the neuro-
cytologist Ramon-y-Cajal. Cajal observed that neu-
 
rons stained with silver contained spherical structures
 
z
 
0.5 
 
m
 
m in diameter which were often associated with nu-
cleoli, and called them nucleolar accessory bodies. Later,
electron microscopists have rediscovered the accessory
body of Cajal and introduced the name coiled body be-
cause when this structure is viewed with the electron micro-
scope it resembles a tangle of coiled threads (Hardin et al.,
1969; Monneron and Bernhard, 1969; Hervás et al., 1980).
The next major advance in the study of coiled bodies
came with the discovery of patient autoimmune sera that
selectively stain these structures and react with a protein
of 
 
z
 
80 kD termed p80–coilin (Raska et al., 1990, 1991;
Andrade et al., 1991). Anti-coilin antibodies proved to be
a very convenient marker for identifying coiled bodies,
and data from numerous laboratories indicate that similar
or equivalent structures are present in nuclei from plants
(Moreno Diaz de la Espina et al., 1980; Beven et al., 1995),
flies (Yannoni and White, 1997), frogs (Gall et al., 1995;
Roth, 1995), birds (Ochs et al., 1995), and mammals (for
review see Bohmann et al., 1995
 
b
 
).
The gene encoding p80–coilin has been cloned and se-
quenced (Andrade et al., 1991; Chan et al., 1994; Wu et al.,
1994; Carmo-Fonseca et al., 1994). The deduced protein
sequence shows no prominent homology to other known
proteins, except for the 
 
Xenopus
 
 protein SPH-1 (Tuma et
al., 1993). This protein is highly homologous to coilin at
both its amino and carboxy termini, but shows much less
homology in the internal domain (see Carmo-Fonseca et
al., 1994). In the nucleus of amphibian oocytes SPH-1 is lo-
calized in spheres that are thought to be equivalent to
coiled bodies (for review see Roth, 1995; Gall et al., 1995).
The coilin sequence includes two motifs at amino acid po-
sitions 107–112 and 181–198 that closely match the consen-
sus sequence of the simple and bipartite nuclear localiza-
 
tion sequence (NLS)
 
1
 
, respectively (Bohmann et al.,
1995
 
a
 
). Mutational analysis data are consistent with both
 
Address all correspondence to M. Carmo-Fonseca, Institute of Histology
and Embryology, Faculty of Medicine, Av. Prof. Egas Moniz, 1699 Lisboa
Codex, Portugal. Tel.: (351) 1 7934340. Fax: (351) 1 7951780. E-mail:
hcarmo@fm.ul.pt
 
1. 
 
Abbreviations used in this paper
 
: Ad2, adenovirus type 2; BrdU, bro-
modeoxyuridine; BrUTP, 5-bromo-2
 
9
 
-uridine-5
 
9
 
-triphosphate; Cy5, in-
dodicarbocyanine; MLP, major late promotor; NLS, nuclear localization
signal; snoRNA, small nucleolar RNA; snRNP, small nuclear ribonucleo-
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NLS motifs having a function in nuclear import. However,
they may contribute differentially to the transport and are
not sufficient to target coilin to the coiled body (Bohmann
et al., 1995
 
a
 
). The protein sequence of p80-coilin include a
high percentage of serine residues, several of which are
phosphorylated in vivo
 
 
 
(Carmo-Fonseca et al., 1993). In a
more recent mutational analysis, a single amino acid
change at position 202, converting the wild-type sequence
from serine to aspartate (which simulates a constitutively
phosphorylated serine), was shown to cause the disappear-
ance of coiled bodies and a redistribution of coilin to intra-
nucleolar domains (Lyon et al., 1997). Similar results were
observed after exposure of cells to the specific Ser/Thr
protein phosphatase inhibitor, okadaic acid, suggesting
that protein dephosphorylation is required for normal
coiled body assembly (Lyon et al., 1997).
In addition to p80-coilin, other components of the coiled
body include the U1, U2, U4/U6, and U5 small nuclear ri-
bonucleoprotein particles (snRNPs) involved in splicing of
pre-mRNA (Carmo-Fonseca et al., 1991
 
a
 
, 1992); the U7
snRNA required for 3
 
9
 
 end processing of histone mRNA
(Frey and Matera, 1995); the nucleolar protein fibrillarin
(Raska et al., 1990, 1991) and the fibrillarin-associated U3
and U8 small nucleolar RNAs (snoRNAs) involved in
processing of pre-rRNA (Wu et al., 1993; Bauer et al.,
1994; Jiménez-Garcia et al., 1994); nucleolar proteins
Nopp140 and NAP57 (Meier and Blobel, 1994) and ribo-
somal protein S6 (Jiménez-Garcia et al., 1994). Finally, the
coiled body contains a number of kinases, namely the cdk-
activating kinase associated with the transcription factor
TFIIH, the cAMP-dependent protein kinase, and the dou-
ble-stranded RNA-activated protein kinase, DAI (Jordan
et al., 1997).
After the initial discovery that coiled bodies are highly
enriched in spliceosomal snRNPs, it was proposed that
they may be functionally related to splicing (Carmo-Fon-
seca et al., 1991
 
a
 
). However, the coiled body does not con-
tain essential non-snRNP protein-splicing factors, such as
SR proteins and U2AF65 (Carmo-Fonseca et al., 1991
 
b
 
,
Gama-Carvalho et al., 1997), and does not accumulate na-
scent transcripts (Huang et al., 1994; Rebelo et al., 1996,
Jordan et al., 1997). Thus, it is unlikely that coiled bodies
represent major sites of pre-mRNA splicing. Conse-
quently, it was suggested that the coiled body may be in-
volved in some aspect of snRNP biogenesis, transport, or
recycling (Lamond and Carmo-Fonseca, 1993; Bohmann
et al., 1995
 
b
 
; Gall et al., 1995).
In the present work we have raised a family of mAbs
that react with distinct amino acid motifs scattered along
the coilin protein. Upon microinjection of HeLa cells into
the nucleus, four distinct antibodies are shown to promote
the disappearance of coiled bodies, thus providing a novel
tool to investigate the function of this subnuclear compart-
ment.
 
Materials and Methods
 
Production of mAbs
 
Two partial human p80-coilin cDNAs were cloned into the His6–tag vec-
tors pRSET B and pRSET A (Invitrogen, Leek, The Netherlands). The
corresponding His–coilin fusion proteins were expressed in 
 
Escherichia
 
coli
 
 and purified using an Ni-NTA agarose affinity column (Quiagen,
Hilden, Germany), as previously described (Bohmann et al., 1995
 
a
 
). For
immunizations, 6-wk-old female BALB/c mice were used. Five animals
were injected with the amino-terminal 127 amino acids of coilin, and an-
other five animals were immunized with the carboxy-terminal 389 amino
acids. The fusion proteins were diluted in 0.1 M sodium phosphate buffer,
pH 8, to a concentration of 0.2 mg/ml, emulsified with Freund’s adjuvant
(Difco Laboratories, Detroit, MI), and then injected intraperitoneally.
Mice were boosted twice at 3-wk intervals and test bleeds were taken. The
sera were screened by immunofluorescence and immunoblotting. The
spleen cells from the two mice with higher antisera titers were fused with
Ag8.653 myeloma cells and hybrids were selected as described by Harlow
and Lane (1988). After 10 d, hybridoma supernatants were tested for reac-
tivity by immunofluorescence and immunoblotting. Of 456 fusion wells,
216 tested positive and six were successfully cloned by limiting dilution on
microtiter plates. These hybridoma cell lines were used to induce a perito-
neal tumor in pristane (Carl Roth, Karlsruhe, Germany) primed adult fe-
male mice (Harlow and Lane, 1988). Ascitic fluid was collected and immu-
noglobulin class, subclass, and light chain type was determined using a
mouse-hybridoma subtyping kit (Boehringer Mannheim, Mannheim, Ger-
many). All mAbs were purified from ascitic fluid by DEAE Affi-Gel blue
chromatography (Bio-Rad Laboratories, Munich, Germany) as described
(Bruck et al., 1982), and subsequently concentrated by ultrafiltration on
Ultrafree-15 membranes (Millipore Corporation, Waters Chromatogra-
phy, Bedford, MA). Purified mAbs were conjugated to lissamine
rhodamine B200 sulfonylchloride (Polysciences, Warrington, PA) by us-
ing standard procedures.
 
Generation and Expression of Full-length and Mutant 
p80–Coilin Constructs
 
Deletion mutants were derived from pKH8 and pBS751.2A (Bohmann et
al. 1995
 
a
 
) by using appropriate restriction enzyme sites. Plasmid pKH8
encodes the carboxy-terminal 389 amino acids of coilin, whereas
pBS751.2A contains the full-length coding region of the protein. Both the
full-length and truncated forms of p80–coilin were expressed in 
 
E
 
.
 
 coli
 
 and
purified as His–tag fusion proteins by Ni-NTA affinity chromatography.
 
Cell Culture
 
HeLa cells were grown as monolayers in minimum essential medium
(MEM) with Earle’s Salts supplemented with 2 mM 
 
l-
 
glutamine, 1%
MEM nonessential amino acids, 50 IU/ml penicillin and 50 mg/ml strepto-
mycin, and 10% fetal calf serum (GIBCO BRL, Paisley, Scotland, UK).
Infection with adenovirus type 2 (Ad2) was performed as described (Re-
belo et al., 1996).
 
SDS-PAGE and Immunoblotting
 
HeLa cells were harvested by trypsinization and crude nuclei were iso-
lated as described (Jordan et al., 1996). Cells and isolated nuclei were
mixed with SDS-PAGE sample buffer (62.5 mM Tris-HCl pH 6.8, 2%
SDS, 5% 
 
b
 
-mercaptoethanol, 10% glycerol, and 0.01% bromophenol
blue) containing 200 U/ml benzonase (Sigma Chemical Co., St. Louis,
MO), incubated for 15 min at room temperature (to digest DNA) and
then boiled for 5 min. Purified His–coilin fusion proteins were directly
boiled in SDS-PAGE sample buffer. Proteins were separated on either 8,
10, 12, or 15% acrylamide gels and transferred to nitrocellulose mem-
branes using a semi-dry electrotransfer apparatus (Bio-Rad Laboratories,
Hercules, CA). The membranes were blocked and washed with 2% nonfat
milk powder in PBS. The blots were incubated for 1 h with primary anti-
bodies diluted in washing buffer, washed three times for 10 min each in
the same buffer, incubated for 1 h with secondary antibodies conjugated
to horseradish peroxidase (Bio-Rad Laboratories) and developed using a
chemiluminescence reaction (enhanced chemiluminescence; Amersham
Int., Buckinghamshire, England, UK).
 
Immunofluorescence
 
For indirect immunofluorescence cells were grown on 10 
 
3 
 
10-mm glass
coverslips. The cells were washed twice in PBS, fixed with 3.7% formalde-
hyde (freshly prepared from paraformaldehyde) in PBS for 10 min at
room temperature, and subsequently permeabilized with 0.5% Triton X-100
in PBS for 15 min at room temperature. Alternatively, cells were first per- 
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meabilized with 0.5% Triton X-100 in CSK buffer (100 mM NaCl, 300 mM
sucrose, 10 mM Pipes, 3 mM MgCl
 
2
 
, 1 mM EGTA, pH 6.8; Fey et al.,
1986) containing 0.1 mM PMSF for 1 min on ice, and subsequently fixed
with 3.7% formaldehyde in CSK buffer, for 10 min at room temperature.
After fixation and permeabilization the cells were rinsed in PBS contain-
ing 0.05% Tween-20 (PBS-Tw), incubated for 30 min with primary anti-
bodies diluted in PBS, washed in PBS-Tw, and then incubated for 30 min
with the appropriate secondary antibodies conjugated to fluorescein
(FITC), Texas red, or indodicarbocyanine (Cy5) (Jackson Immuno-
Research Laboratories, West Grove, PA). Finally, the coverslips were
mounted in VectaShield (Vector Laboratories, Peterborough, UK) and
sealed with nail polish.
 
Visualization of Replication and Transcription Sites
 
For the visualization of replication sites, 50 
 
m
 
M bromodeoxyuridine
(BrdU; Boehringer Mannheim) was added to the culture medium for ei-
ther 2 or 24 h. To detect the incorporated BrdU, the cells were permeabi-
lized with 0.5% Triton X-100 and fixed in formaldehyde as described
above. The cellular DNA was denatured by incubation in 1.5 M HCl for
10 min at room temperature. Detection of BrdU-DNA was performed by
indirect immunofluorescence using purified sheep anti-BrdU polyclonal
antibody (Biodesign International, Kennebunk, ME) and a secondary an-
tibody coupled to fluorescein.
For the detection of nucleoplasmic transcription 5-bromo-2
 
9
 
-uridine-
5
 
9
 
-triphosphate (BrUTP, 5 
 
m
 
M of solution; Sigma Chemical Co.) was mi-
croinjected into the cytoplasm of HeLa cells. The cells were further incu-
bated for 10 min at 37
 
8
 
C, permeabilized with 0.5% Triton X-100, and fixed
in formaldehyde as described above. The incorporated bromo-uridine was
detected using a monoclonal antibody directed against BrdU (Boehringer
Mannheim) and a secondary antibody labeled with fluorescein.
 
In Situ Hybridization
 
For in situ hybridization, cells were fixed with 3.7% formaldehyde in CSK
buffer for 10 min at room temperature and subsequently permeabilized
with 0.05% SDS in 100 mM Tris-HCl, pH 7.5, 150 mM NaCl, 12.5 mM
EDTA, for 5 min. Detection of spliced transcripts was performed using
synthetic oligonucleotide probes, as previously described (Zhang et al.,
1994; Bridge et al., 1996). Detection of U2 snRNA, U3 snoRNA, and 28S
rRNA was performed using biotinylated 2
 
9
 
-O-allyl oligoribonucleotide
probes, as previously reported (Carmo-Fonseca et al., 1992).
 
Confocal Microscopy
 
Samples were analyzed with the laser-scanning microscope LSM410 (Carl
Zeiss, Inc., Thornwood, NY). Argon ion (48-nm), HeNe (54-nm), and Kr
(63-nm) lasers were used to excite FITC, Texas red, and Cy5 fluores-
cences, respectively.
 
Microinjections and Live Cell Observations
 
For microinjection experiments, cells were grown on either 10 
 
3 
 
10-mm
glass coverslips or CELlocate coverslips (Eppendorf Scientific, Hamburg,
Germany). Micropipettes obtained from Clark Electromedical Instru-
ments (Pangbourne, UK) were freshly prepared on a P-87 puller (Sutter
Instruments, Novato, CA) and microinjections were performed using ei-
ther an Eppendorf microinjector 5242 (Eppendorf Scientific, Inc., Ham-
burg, Germany) or the AIS system (Ansorge and Pepperkok, 1988). Puri-
fied mAbs were microinjected at concentrations ranging between 2.5 and
5 mg/ml. Plasmid DNA was microinjected at 0.1 mg/ml. For live cell ob-
servations, the cells were grown in glass bottom microwell dishes (MatTek
Corporation, Ashland, MA) placed in a temperature-controlled chamber
on the stage of an inverted microscope (Carl Zeiss, Inc., Oberkochen,
Germany). The medium in the dish was overlaid with mineral oil to slow
evaporation. Images were acquired with a Photometrics (Tucson, AZ)
cooled slow scan charge-coupled device camera CH250 with a CE200A
camera control unit, using a 63
 
3
 
, 1.4 NA Plan Apo oil immersion lens
(Carl Zeiss, Inc.). The system included motorized shutters and filter
wheels with a SUN Sparcstation 10/41 providing automated time-lapse
data collection using the KHOROS software, as previously described
(Herr et al., 1993).
 
Results
 
Specificity of Anti-coilin mAbs
 
To obtain monoclonal antibodies, hybridomas were de-
rived by fusion of the mouse myeloma cell line Ag8.653
with spleen cells from Balb/c mice immunized with recom-
binant human coilin. Six clones (designated 
 
d
 
, p
 
d
 
, 
 
g
 
, 
 
p
 
, 
 
o
 
,
and 
 
f
 
) were isolated. The antibodies secreted by clones 
 
d
 
,
p
 
d
 
, 
 
o
 
, and 
 
f
 
 
 
are of the IgG1 class, whereas mAb-
 
g
 
 is
IgG2b and mAb-
 
p
 
 is IgG2a (Table I). Immunoblot analy-
sis reveals that all mAbs recognize a band of 
 
z
 
80 kD in
HeLa protein extracts (Fig. 1, 
 
A
 
 and 
 
B
 
). Clones
 
 
 
p 
 
and 
 
d
 
 re-
act specifically with p80–coilin, whereas the other clones
cross-react with additional peptides. In addition to coilin,
the mAbs 
 
o
 
 and 
 
g
 
 recognize a major cytoplasmic protein
band of 
 
z
 
140 kD, mAb-
 
f
 
 strongly reacts with a nuclear
Figure 1. Immunoblot analysis of anti-coilin mAbs. An 8% acryl-
amide gel was loaded with either total protein extract from HeLa
cells (2 3 105 cells/well) (A) or a protein extract from isolated
HeLa cell nuclei (106 cell equivalents/well) (B). Immunoblot
analysis was performed using the following antibodies: rabbit an-
tiserum 204.3 (diluted 1:20,000) (lane 1); mAb-o (25 mg/ml puri-
fied IgG) (lane 2); mAb-f (10 mg/ml purified IgG) (lane 3);
mAb-g (25 mg/ml purified IgG) (lane 4); mAb-p (5 mg/ml puri-
fied IgG) (lane 5); mAb-d (0.08 mg/ml purified IgG) (lane 6);
mAb-pd (15 mg/ml purified IgG) (lane 7); mouse antiserum 25.3
(diluted 1:5,000) (lane 8); and nonspecific polyclonal mouse IgG
(5 mg/ml purified IgG) (lane 9). Due to significant differences in
the binding affinity of each mAb, different antibody concentra-
tions were used in order to produce a signal of similar intensity.
Antiserum 25.3 derives from the mouse used to produce hybrido-
mas f, g, p, d, and pd. Nonspecific mouse IgG was purchased
from Sigma Chemical Co. Molecular mass markers (kD) are indi-
cated on the left. 
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protein of 
 
z
 
110 kD, and mAb-p
 
d
 
 reveals a minor nuclear
protein band of 
 
z
 
115 kD. To map the epitopes recognized
by each mAb, a series of His–coilin deletion mutants was
generated and probed by immunoblot analysis (Fig. 2).
From these data we conclude that the different clones re-
act with epitopes distributed along the entire protein se-
quence. By immunofluorescence all mAbs labeled coiled
bodies (Fig. 3 
 
A
 
 and data not shown), as previously re-
ported for clone 
 
d
 
 (Rebelo et al., 1996).
 
Microinjection of mAbs Affect the Coiled
Body Structure
 
To determine whether the mAbs interfere with coiled
bodies in the native environment of the living cell nucleus,
each antibody was purified from ascitic fluid and microin-
jected into the nuclei of interphase HeLa cells. The cells
were immediately removed from the microscope stage,
permeabilized with detergent, fixed, and then incubated
with fluorescent secondary antibodies. The time between
injection and fixation was 
 
z20 min. As shown in Fig. 3 B,
injected mAb-d binds to coiled bodies within this time pe-
riod, producing a labeling pattern similar to that obtained
by indirect immunofluorescence on fixed cells (Fig. 3 A).
In contrast, when cells are observed 24 h after injection of
mAb-d the coiled bodies are no longer visible (Fig. 3 C),
suggesting that binding of mAb-d to coilin affects the
structure of the coiled body. To further confirm this idea,
similar experiments were performed using mAb-d prein-
cubated with recombinant coilin protein. Purified mAb-d
was incubated for 1 h with increasing concentrations of
coilin and then used for indirect immunofluorescence on
fixed cells. As shown in Fig. 3 D, no signal was detected af-
ter incubation of mAb-d with a 1:2 molar excess of coilin,
indicating that all antigen binding sites had been blocked.
The same preparation of neutralized mAb-d was then mi-
croinjected into the nucleus of HeLa cells. As expected
from its inability to bind to endogenous coilin, immedi-
ately after injection mAb-d appears diffuse throughout the
nucleoplasm (Fig. 3 E, also see B). However, there is an
additional faint staining of coiled bodies (Fig. 3 E, arrow),
implying that in vivo a small fraction of IgG molecules is
still able to bind to endogenous coilin. This could be due
to a progressive exchange of recombinant coilin by endo-
Figure 2. Epitope mapping of mAbs. (A) Dia-
gram showing the reactivity of each mAb with the
full-length coilin and different deletion mutants
of the protein, as determined by immunoblot
analysis. The data show that the epitopes recog-
nized by mAbs o, f, and g map between amino
acids 1–127, 187–291, and 292–362, respectively.
The mAbs d and pd react with epitopes located
between acids 363 and 481. The mAb-p recog-
nizes either an epitope localized around amino
acids 481–482, or a conformational epitope
present in the coilin mutant encompassing amino
acids 363–576, but absent from the mutants en-
compassing amino acids 363–481 and 482–576.
(B) Diagram showing the mapped epitopes (Y) in
relation to the complete coilin sequence. Hatched
regions depict the two motifs that closely match
the consensus sequence of simple and bipartite
nuclear localization sequences, NLSa and NLSb,
respectively (Bohmann et al., 1995a). The dia-
gram also depicts the position of serine 202. Con-
version of this amino acid residue into aspartate
causes the disappearance of coiled bodies and a
redistribution of coilin to intranucleolar domains
(Lyon et al., 1997).
Table I. Immunoglobulin Class, Subclass, and Light Chain 
Typing of Anti-coilin mAbs
mAb Abbreviated name Ig subtype
1D4-dd IgG1/k
5P11-pd pd IgG1/k
1G3-gg IgG2b/k
5P10-pp IgG2a/k
3W8-oo IgG1/k
4F9-ff IgG1/kAlmeida et al. Microinjection of Anti-coilin Antibodies 903
genous coilin (possibly, the mAb binds to endogenous coi-
lin with higher affinity and/or avidity). Accordingly, 24 h
after injection the fluorescent signal is predominantly con-
centrated in coiled bodies (Fig. 3 F). Most important, these
results show that coiled bodies remain intact when cells
are microinjected with mAb-d neutralized with recombi-
nant coilin.
Although coilin is predominantly concentrated in the
coiled body, there is a variable amount of the protein in
the nucleoplasm and our previous results suggest that coi-
lin may shuttle between the two pools (Rebelo et al.,
1996). We therefore predict that microinjected IgG mole-
cules bind to coilin and may subsequently become incor-
porated into a coiled body. In fact, coiled bodies are
brightly labeled shortly after microinjection of mAb-d into
the cytoplasm of HeLa cells (Fig. 3 G). Because IgG mole-
cules per se are unable to cross the nuclear pores (Borer et
al., 1989), it is most likely that antibody–coilin complexes
formed in the cytoplasm are actively translocated to the
nucleus (as a consequence of the nuclear localization sig-
nals present in the coilin protein) and once in the nucleus,
the antibody–coilin complexes are rapidly incorporated
into coiled bodies. Consistent with this interpretation, no
nuclear staining is observed when mAb-d is microinjected
into cells devoid of cytoplasmic coilin due to the presence
of a protein synthesis inhibitor (Fig. 3 H).
Injection of mAbs pd, g, p, o, and f into the nucleus of
HeLa cells produce results similar to those observed with
mAb-d, i.e., rapid staining of the coiled body (Fig. 4, A–C
and G–I). Intriguingly, mAbs o and f stain nucleoli in ad-
dition to coiled bodies (Fig. 4, H and I, arrowheads). The
intranucleolar staining produced by mAb-o is diffuse (Fig.
4 H, arrowheads), increases in intensity with time after mi-
croinjection (Fig. 4 K, arrowhead) and is never observed
by indirect immunofluorescence, suggesting that it may re-
flect an unspecific accumulation of injected antibody in
the nucleolus. In contrast, mAb-f stains intranucleolar
foci (Fig. 4 I, arrowheads) which are also detected by indi-
rect immunofluorescence on fixed cells. Double-labeling
experiments using antibodies directed to RNA poly-
merase I and UBF reveal that these intranucleolar foci
correspond to sites of rRNA synthesis (data not shown;
Jordan at al., 1996). Interestingly, the epitope recognized
by mAb-f is adjacent to a critical serine residue (serine
202) which when mutated to aspartate induces the forma-
tion of coiled body-like structures inside the nucleolus
(Lyon et al., 1997; refer to Fig. 2 B). However, this type of
intranucleolar labeling was never observed with anti-coilin
Figure 3. Microinjection mAb-d. (A) HeLa
cells were permeabilized with Triton
X-100, fixed with formaldehyde, and then
incubated with mAb-d. (B and C) HeLa
cells were microinjected in the nucleus
with mAb-d. The cells were then observed
immediately (B) or 24 h after injection (C).
(D–F) Purified mAb-d was incubated for
1 h with 1:2 molar excess of a coilin peptide
containing the epitope for this antibody
(amino acids 363–481). The neutralized
mAb was then used for indirect immuno-
fluorescence on fixed cells (D) or microin-
jected in the nucleus of living cells (E and
F). (E) Immediately after injection the
neutralized mAb is diffusely distributed
throughout the nucleoplasm with addi-
tional staining of a coiled body (arrow).
Note the bright pericellular staining which
is due to antibody–antigen complexes ad-
sorbed to the cell membrane. (F) 24 h after
injection the staining is predominantly
concentrated in coiled bodies. (G and H)
HeLa cells were microinjected in the cyto-
plasm with mAb-d and observed 1 h after
injection. The cells were either nontreated
(G) or treated with 10 mg/ml emetine for
2.5 h before injection (H). Bar, 10 mm.The Journal of Cell Biology, Volume 142, 1998 904
polyclonal antibodies, making it difficult to conclude that
it represents an additional localization of coilin within the
nucleolus. Rather, it is more likely that mAb-f recognizes
an epitope common to coilin and another nuclear protein
of z110 kD, as revealed by immunoblotting (refer to Fig.
1, A and B, lane 3).
Similar to the results obtained with mAb-d (Fig. 4, A
and D), when cells are injected with mAb-pd and observed
24 h later, coiled bodies are no longer visible (Fig. 4, B and
E). Cells injected with mAb-g for 24 h still contain coiled
bodies but these appear smaller than in normal cells (Fig.
4, C and F). In contrast, coiled bodies with an apparent
normal morphology are observed in cells injected with
mAb-p for 24 h (Fig. 4, G and J). Finally, injection of
mAbs  o and f for 24 h induces the disappearance of coiled
bodies without affecting the nucleolar staining (Fig. 4, H,
K, I, and L). Noteworthy, by 24 h after injection most
mAbs reveal an intense micropunctate staining pattern
diffusely distributed throughout the nucleoplasm, exclud-
ing the nucleolus (Fig. 4, A and D, B and E, C and F, and
H and K). This effect is not observed with mAb-p, which
stains predominantly coiled bodies at both 0 and 24 h after
injection (Fig. 4, G and J), and mAb-f, which labels intra-
nucleolar foci (Fig. 4, I and L).
Although coilin microfoci become more prominent after
the disappearance of coiled bodies, similar structures are
present in nontreated cells and we have previously demon-
strated that at the electron microscopy level they corre-
spond to microspherules of z0.05 mm in diameter (Rebelo
et al., 1996). Furthermore, we show here that neither
coiled bodies nor coilin microfoci colocalize with sites of
incorporation of brominated UTP, indicating that they do
not correspond to transcription sites (Fig. 5, A and B).
To further characterize the effect of microinjected anti-
bodies on the coiled body, a quantitative analysis was per-
formed. Each mAb was injected into the nuclei of inter-
phase HeLa cells and at 0, 6, and 24 h after injection the
cells were fixed, incubated with fluorescein-conjugated
secondary antibodies, and then double-labeled with a rab-
bit anti-coilin antiserum (204.3) detected using Texas red
fluorescence. For each time point, the proportion of in-
jected cells with coiled bodies was estimated and the val-
Figure 4. The effect of mAb injection on
coiled bodies. HeLa cells were microin-
jected in the nucleus with mAbs d (A and
D), pd (B and E), g (C and F), p (G and J),
o (H and K), and f (I and L). The cells
were observed either immediately after in-
jection (A–C, G–I) or 24 h after injection
(D–F,  J–L). For microscopical observa-
tion, the cells were permeabilized with Tri-
ton X-100, fixed, and incubated with a sec-
ondary antibody coupled to fluorescein.
Note that mAbs o and f label both coiled
bodies (arrows) and nucleoli (arrow-
heads). Bar, 10 mm.Almeida et al. Microinjection of Anti-coilin Antibodies 905
ues at time zero were taken as reference (Fig. 6). The re-
sults show that immediately after injection, the proportion
of injected cells containing coiled bodies identified by anti-
serum 204.3 was similar to that of noninjected cells. At 6
and 24 h after injection, the proportion of noninjected cells
containing coiled bodies remained unaltered, whereas in-
jected cells showed significant changes. The mAbs d, o,
and f induce a drastic disappearance of coiled bodies. The
mAb pd also reduces the proportion of cells with coiled
bodies, although less efficiently than the previous ones.
The mAb-g induces a slight decrease in the proportion of
injected cells containing coiled bodies at 6 h after injec-
tion, but this value remains roughly unchanged by 24 h af-
ter injection. In striking contrast with these results, mAb-p
causes an increase in the relative numbers of injected cells
containing coiled bodies.
Importantly, the morphological patterns produced by
each mAb at 24 h after injection are maintained up to 3 d,
indicating that within this time period, the antibodies are
not lethal to the cells and remain stable in the nucleus.
Furthermore, addition of BrdU to the culture medium of
cells injected for 24–48 h with either mAb-d or mAb-p in-
dicates that DNA synthesis and mitosis are occurring at
approximately the same rates among injected and nonin-
jected cells (data not shown).
In conclusion, we have produced monoclonal antibodies
which, depending on their binding sites on coilin, are able
to differentially interfere with the structure of the coiled
body in vivo.
Visualization of Coiled Bodies in Living Cells
To clarify the mechanisms by which the anti-coilin anti-
bodies are affecting the coiled body, images of live cells
were recorded at 20–30-min intervals after injection of
mAbs coupled to rhodamine.
Injection of rhodamine-labeled mAb-p into the nucleus
reveals intensely labeled coiled bodies, which do not ap-
pear to change their relative positions during the time-
lapse observations (Fig. 7, A–F). Injection of the antibody
in the cytoplasm is rapidly followed by transport to the nu-
cleus and incorporation into coiled bodies (Fig. 7, A–D, ar-
rows). Importantly, microinjected cells undergo mitosis
(Fig. 7, C and F, arrowheads) and labeled coiled bodies are
seen in the daughter cells (Fig. 7 E, arrows). This demon-
strates that, first, microinjection is not perturbing normal
cell physiology and, second, binding of mAb-p to coilin is
not preventing de novo assembly of coiled bodies.
In contrast with the above observations, injection of
rhodamine-labeled mAb-d into the nucleus shows a pro-
gressive disappearance of coiled bodies over a period of
z6 h (Fig. 8, A–G). However, coiled bodies are readily vis-
ible immediately after injection into the nucleus (Fig. 8 A)
or shortly after injection into the cytoplasm (refer to Fig. 3
G). Thus, binding of mAb-d is not preventing the assembly
of coilin–antibody complexes into coiled bodies. Possibly,
when complexes of mAb-d with coilin are incorporated
into a coiled body they block the subsequent assembly of
new protein, leading to a progressive disappearance of the
structure due to its normal turnover rate. Alternatively,
the presence of mAb-d/coilin complexes in a coiled body
Figure 5.  Coilin does not colocalize with transcription sites. (A)
HeLa cells were microinjected with Br-UTP in the cytoplasm,
fixed, and then immunolabeled with mAb-p. The sites of incor-
porated Br-uridine are stained green and the sites containing coi-
lin are stained red. Note that coilin is present both in coiled
bodies (arrows) and in numerous nucleoplasmic microfoci (ar-
rowheads). (B) HeLa cells were injected in the nucleus with
mAb-d. 24 h later the cells were reinjected in the cytoplasm with
Br-UTP. Note that the coilin microfoci (stained red) do not colo-
calize with transcription sites (stained green). Bar, 10 mm.
Figure 6. Quantitative analysis of the effects of mAb injection on
coiled bodies. Cells were microinjected in the nucleus with mAbs
d, pd, g, p, o, and f. The cells were either immediately permeabi-
lized and fixed (t0), or further incubated for 6 or 24 h. The in-
jected mAb was detected using fluorescein-conjugated secondary
antibodies. Cells were double-labeled with a rabbit anti-coilin an-
tiserum (204.3) detected using Texas red fluorescence. For each
mAb, the percentage of injected cells with coiled bodies was esti-
mated at each time point (CB[tn]), and the values at time zero
(CB[t0]) were taken as reference. For each mAb, at least three in-
dependent microinjection experiments were performed. The to-
tal number of cells counted per mAb at each time point ranged
between 100 and 600.The Journal of Cell Biology, Volume 142, 1998 906
may somehow trigger its disassembly. After their disap-
pearance, coiled bodies are no longer visible in cells in-
jected with mAb-d, indicating that the antibody continues
to exert its effect for a period of at least 39 h (Fig. 8, H–L).
During this period, the injected cells remain viable, as
shown by their ability to divide (Fig. 8, K and L, arrows).
Injection of rhodamine-labeled mAbs o and f also pro-
duces a progressive disappearance of coiled bodies,
whereas after injection of mAb-g coiled bodies remain vis-
ible, although they often appear to become smaller
throughout the time-lapse analysis (data not shown).
Irrespective of the mAb used for injection, coiled bodies
maintain their relative positions throughout the time-lapse
observations. Although this would argue against the view
that coiled bodies may act as carriers or transporters inside
the nucleus, we cannot exclude that binding of the mAbs
to coilin may exert an inhibitory effect on presumptive
motion.
Coiled Body Disappearance Does Not Affect snRNP 
Localization or Nucleolar Structure
Having established that intranuclear injection of mAbs
promotes the disappearance of coiled bodies, we next
asked how depriving a cell of the coiled body affects the
subcellular distribution of splicing snRNPs. The U1, U2,
U5, and U4/U6 snRNPs, all of which are localized in the
coiled body, represent major components of the spliceo-
some. Each of these snRNPs is built of a unique species of
snRNA associated with specific proteins. Additionally, all
splicing snRNPs share a common set of proteins, termed
the Sm proteins, that are tightly bound to the snRNAs (for
review see Moore et al., 1993). During their biogenesis,
the U1, U2, U4, and U5 snRNAs are transcribed in the nu-
cleus and transported to the cytoplasm, where the Sm pro-
teins bind. Thereafter, the assembled snRNP is imported
to the nucleus (for review see Mattaj, 1988). In the nu-
Figure 7. Analysis of mAb-p in living cells. HeLa
cells were injected with rhodamine-labeled mAb-
p and analyzed at 30-min intervals. All cells in
this field were injected in the nucleus, except one
that was injected in the cytoplasm (A and B, ar-
rowheads). The time between injection and the
first observation was z20 min. Note that shortly
after injection, the antibody injected in the cyto-
plasm (A and B, arrowheads) labels coiled bodies
(A–D, arrows). At 1.5 h after the first observa-
tion, one cell initially injected in the nucleus has
entered mitosis (arrowhead), and 3 h later coiled
bodies are labeled in the daughter cell nuclei (E,
arrows). At 6 h after the first observation, an-
other cell is in mitosis and contains a labeled mi-
totic coiled body in the cytoplasm (F, arrow-
head). Bar, 10 mm.Almeida et al. Microinjection of Anti-coilin Antibodies 907
cleus, snRNPs are normally distributed throughout the nu-
cleoplasm with additional concentration in interchromatin
granules and coiled bodies (for review see Lamond and
Carmo-Fonseca, 1993). To investigate whether the coiled
body plays an important role in the subcellular distribu-
tion of snRNPs, cells were microinjected with mAb 1D4-d,
incubated for 24 h, fixed, and then double-labeled with ei-
ther an antisense riboprobe specific for U2 snRNA (Fig. 9,
A and B) or an antibody against the Sm proteins (Fig. 9, C
and D). As depicted in the figure, no apparent change is
observed in the distribution of either U2 snRNA or Sm
protein in injected cells. Namely, there is no evidence for
an accumulation of snRNA or Sm protein in the cyto-
plasm, and within the nucleus the distribution appears nor-
mal, except for the lack of accumulation at coiled bodies
which is typically observed in noninjected cells (Fig. 9 B,
arrows). Similar results were observed on cells microin-
jected with mAb 1D4-d and incubated for 48 h before fixa-
tion and labeling (data not shown).
In a recent work, Bohmann and colleagues (1995a) re-
ported that overexpression of mutated forms of the human
p80 coilin gene induces a disorganization of both the
coiled body and the nucleolus, suggesting that the two
structures share either a common structural framework or
a common assembly pathway. We therefore asked whether
microinjection of antibodies that promote the disappear-
ance of coiled bodies perturbs the organization of the nu-
cleolus. Fig. 9, E and F depict a field of cells that were mi-
croinjected with mAb 1D4-d, incubated for 48 h, fixed, and
then double-labeled with a riboprobe specific for U3
snoRNA. This small RNA associates with fibrillarin to
form ribonucleoprotein particles that are normally local-
ized in both the nucleolus and the coiled body. The results
show that the distribution of U3 in injected cells is indistin-
guishable from that of noninjected cells. Similar results
were observed using probes specific for other nucleolar
components such as 28S rRNA and RNA polymerase I,
after microinjection of three distinct mAbs that promote
the disappearance of coiled bodies, namely 1D4-d, 3W8-o,
and 4F9-f (data not shown). Since the structural organiza-
tion of the nucleolus is strictly dependent upon ongoing
biogenesis of rRNA (for review see Shaw and Jordan,
1995), the data strongly suggest that the disassembly of the
coiled body is not affecting nucleolar function. Thus, mi-
croinjection of anti-coilin antibodies is specifically inter-
fering with coiled bodies.
Coiled Body Disappearance Does Not Impair Splicing
of Pre-mRNAs
Although the disappearance of coiled bodies induced by
antibody microinjection does not alter the subnuclear dis-
tribution of spliceosomal snRNPs, we have further investi-
gated whether it interferes with their metabolism and, con-
sequently, with splicing. To perform these experiments we
initially chose to infect cells with Ad2, and test the ability
of injected cells to support splicing of the well-character-
ized viral major late pre-mRNA. Adenovirus contains a
single major late promoter (MLP) that is strongly acti-
vated after the onset of viral replication, at z8 h after in-
fection, and attains maximal activity by 18 h after infec-
tion. The MLP encodes a large primary transcript that
gives rise to five families of mRNAs (L1–L5) by differen-
tial splicing and polyadenylation (Sharp, 1984). Each of
these mRNAs have in common a 59 noncoding region of
201 nucleotides, which is called the tripartite leader and is
derived by the splicing of three small introns.
In a previous study we have shown that coiled bodies
Figure 8. Analysis of mAb-d in living cells. HeLa
cells were injected with rhodamine-labeled mAb-
d and analyzed at 30-min intervals. All cells in
this field were injected in the nucleus. The time
between injection and the first observation was
z20 min. Within 6 h after the first observation,
the coiled bodies progressively disappear (A–G).
At later time points coiled bodies are never de-
tected in these cells (H–L). Note that one of the
cells has divided by 39 h (L, arrows). J and L de-
pict phase-contrast images corresponding to I
and  K, respectively. Bar, 10 mm.The Journal of Cell Biology, Volume 142, 1998 908
disassemble by 16–18 h of viral infection, most likely as a
consequence of the block in host cellular protein synthesis
induced by the virus (Rebelo et al., 1996). However, coiled
bodies are present during the early stages of Ad2 infec-
tion, suggesting that they might be required during the pe-
riod of activation of viral late gene expression.
In this study, cells were microinjected with mAb 1D4-d,
incubated for either 6 or 24 h, and then infected with Ad2
for 18 h (Fig. 10, A–D). The cells were fixed and hybrid-
ized with an oligonucleotide probe complementary to the
first splice junction of the tripartite leader (Bridge et al.,
1996). To unambiguously identify cells that were simulta-
neously injected and infected, a triple-labeling experiment
was performed using rhodamine to detect the injected
mAb, Cy5 for the viral protein DBP (Linné et al., 1977),
and fluorescein for spliced viral mRNA. As shown in Fig.
10, A and B, the hybridization signal produced by the
splice junction probe is similar in injected (Fig. 10 A, ar-
row) and noninjected cells (Fig. 10 A, arrowheads). Similar
results were observed on cells microinjected with mAb
1D4-d, incubated for 24 h, and then infected with Ad2 for
18 h (Fig. 10, C and D). Similar results were also observed
after injection of mAbs 3W8-o (which also promotes dis-
appearance of coiled bodies) and 5P10-p (which does not
disassemble coiled bodies; data not shown). Immunofluo-
rescence analysis of injected cells using antibodies against
the penton protein further confirmed that late viral gene
expression was active in these cells (data not shown).
From these data we conclude that coiled bodies are not
required to support either the early phase of infection (in-
volving expression of a small number of proteins which
prime the infected cell for the late phase) or the splicing of
late viral mRNA.
Taking into account that viruses have evolved mecha-
nisms to subvert the host cell machinery and that large
amounts of partially spliced viral mRNAs accumulate in
the nucleus of infected cells (Sharp, 1984), we next asked
whether disappearance of coiled bodies affects splicing of
a nonviral pre-mRNA. For this, HeLa cells were first coin-
jected with a transient expression vector carrying a human
b-globin gene in the SV-40 epissomal vector pbSV328
(Grosveld et al., 1982) and an unspecific mouse IgG. After
incubation for 6–24 h, the cells were fixed and double-
labeled with an anti-mouse secondary antibody (to iden-
tify injected cells) and oligonucleotide probes complemen-
tary to either the first or the second splice junction of
Figure 9. Coiled body disappearance does
not affect snRNP localization. HeLa cells
were microinjected with mAb-d and incu-
bated for either 24 (A–D) or 48 h (E and
F) before fixation. The injected antibody
was detected using a secondary antibody
conjugated to Texas red (A, C, and E).
The cells were double-labeled with either
an antisense riboprobe specific for U2 sn-
RNA (B), an antibody against the Sm pro-
teins (D), or an antisense riboprobe spe-
cific for U3 snoRNA (F). Arrows in B
point to U2 snRNA concentrated in the
coiled bodies of noninjected cells. Bar,
10  mm.Almeida et al. Microinjection of Anti-coilin Antibodies 909
b-globin mRNA (Custódio, N., M. Carmo-Fonseca, and
M. Antoniou, unpublished data). From these experiments
we concluded that maximal levels of spliced globin RNA
were detected in the cytoplasm by 16 h after injection.
Next, cells were injected with mAb-d, incubated for 24 h,
reinjected with b-globin plasmid DNA, and then further
incubated for 16 h. The results obtained after hybridiza-
tion using a probe complementary to the first splice junc-
tion of b-globin mRNA clearly indicate that the antibody-
induced absence of coiled bodies is not preventing the
accumulation of spliced b-globin mRNA in the cytoplasm
(Fig. 10, E and F). Similar results were observed after hy-
bridization using a probe complementary to the second
splice junction of b-globin mRNA, or after injection of
mAb-o (which also promotes disappearance of coiled bod-
ies) and mAb-p (which does not disassemble coiled bod-
ies; data not shown).
In conclusion, the results show that high levels of splicing
activity are taking place in nuclei devoid of coiled bodies.
Discussion
Microinjection of Anti-coilin Antibodies Induces the 
Disappearance of Coiled Bodies
We have demonstrated the feasibility of using anti-coilin
antibodies to specifically interfere with the structure of
coiled bodies in the nucleus of living cells. Monoclonal an-
tibodies were raised against the coiled body protein p80-
coilin, purified, and then microinjected into the nucleus of
HeLa cells. Visualization was achieved by either staining
of fixed cells or direct in vivo imaging using rhodamine-
labeled antibody. The ability to carry out extended in vivo
analysis was demonstrated by direct observation of injected
cells undergoing cell division over a period of 24–48 h.
After microinjection into the nucleus, all mAbs labeled
coiled bodies. Taking into account that a pool of intranu-
clear coilin is concentrated in coiled bodies and another
pool is scattered throughout the nucleoplasm (refer to Fig.
Figure 10. Coiled body dis-
appearance does not impair
splicing. (A–D) HeLa cells
were microinjected with
mAb-d, incubated for either 6
(A and B) or 24 h (C and D)
and then infected with Ad2
for 18 h. The cells were fixed
and hybridized with an oligo-
nucleotide probe comple-
mentary to the first splice
junction of the tripartite
leader (A and C). The in-
jected antibody was detected
using a secondary antibody
conjugated to Texas red (B
and D), and the viral protein
DBP was detected using a
secondary antibody conju-
gated to Cy5 (data not
shown). The hybridization
pattern in the injected cells
(A,  arrow; and C) is similar to
that of noninjected cells (A,
arrowheads). Note that in B
and D, staining of the nucleo-
plasm is nonhomogeneous.
This is due to the very intense
signal produced by anti-DBP
antibody, which is partially
detected in the Texas red
channel of the confocal mi-
croscope. (E and F) Cells
were microinjected with mAb
1D4-d, incubated for 24 h,
and then re-injected with a
expression plasmid carrying
the human b-globin gene.
The cells were fixed 16 h later
and hybridized with an oligonucleotide probe complementary to the first splice junction of b-globin mRNA (E). The injected antibody
was detected using a secondary IgG conjugated to Texas red (F). Note that under the mild permeabilization conditions used here, the
hybridization signal is predominantly detected in the cytoplasm. Bar, 10 mm.The Journal of Cell Biology, Volume 142, 1998 910
3 A), this result may reflect either binding of the injected
antibody to coilin molecules present in coiled bodies, or
binding to nucleoplasmic coilin with subsequent assembly
of antibody–coilin complexes into coiled bodies. The find-
ing that coiled bodies become labeled upon microinjection
of the antibody into the cytoplasm supports the latter in-
terpretation, and it is possible that both mechanisms may
occur when the antibody is injected into the nucleus.
Within 24 h after injection, two distinct antibody-
induced phenotypes are clearly identified. The mAbs d, o,
and f cause the disappearance of coiled bodies (as con-
firmed by double-labeling using an anti-coilin rabbit se-
rum) in .90% of injected cells. In contrast, mAb-p has no
apparent effect on the integrity of the coiled body and
mAb-g induces only a slight decrease (,20%) in the num-
ber of cells with coiled bodies. Most probably, the first
phenotype is caused by the fact that antibody-coilin com-
plexes incorporated in a coiled body impair the subse-
quent assembly of new coilin molecules. This may either
directly trigger disassembly of the structure or simply lead
to its disappearance as a consequence of its high turnover
rate. In fact, two lines of evidence suggest that the coiled
body goes through a rapid cycle of assembly/disassembly
in the nucleus. First, exogenous coilin is able to correctly
localize in coiled bodies, although overexpression of the
protein fails to increase their size or number (Wu et al.,
1994; Bohmann et al., 1995a). Second, treatment of cells
with inhibitors of protein synthesis causes a progressive
disappearance of coiled bodies (Lafarga et al., 1994; Re-
belo et al., 1996).
Remarkably, the mAbs capable of interfering with the
coiled body bind to epitopes spread throughout the coilin
protein (refer to Fig. 2). In good agreement with this, it
was previously reported that removal of either amino- or
carboxy-terminal sequences of p80–coilin prevented inter-
action with coiled bodies (Bohmann et al., 1995a). Taken
together, these data suggest that assembly of coilin into
coiled bodies requires multiple sequence motifs scattered
along the protein.
Coiled Body Disappearance Does Not Impair Splicing
Currently proposed hypothesis for the function of the
coiled body are based on the idea that this structure is
somehow involved in snRNP metabolism (see Bohmann
et al., 1995b). According to the model that snRNPs must
cycle through the coiled body in order to be recycled, as-
sembled or modified de novo, one prediction would be
that in the absence of coiled bodies either preexisting or
newly synthesized snRNPs would become unavailable for
spliceosome assembly. Although slow proliferating cells
such as primary human fibroblasts are normally devoid of
coiled bodies (Huang and Spector, 1992), they contain coi-
lin and may assemble coiled bodies (Carmo-Fonseca et al.,
1993). Possibly, in the presence of low levels of splicing ac-
tivity the requirements for snRNP recycling or de novo
synthesis are so low that coiled bodies form only tran-
siently or are too small to be clearly identified with the
light microscope. Consistent with this view, coiled bodies
are conspicuous in metabolically activate cells and become
more numerous upon stimulation of gene expression
(Ochs et al., 1995). Therefore, to determine whether the
disappearance of coiled bodies affects snRNP function, it
is important to overload the nucleus with highly abundant
intron-containing transcripts. Furthermore, taking into ac-
count that the half-lives of spliceosomal snRNPs are z20 h
(Moore et al., 1993), it is crucial to analyze cells devoid of
coiled bodies for long periods of time.
Here we have microinjected mAbs that induce disap-
pearance of coiled bodies, incubated the cells for 24 h, and
then infected them with adenovirus. The human Ad2
causes a productive infection of HeLa cells that proceeds
through an infectious cycle of z36 h (for review see Hor-
witz, 1990). This cycle is conventionally divided into early
and late stages, separated by the onset of viral replication
which occurs at z8 h after infection. After the onset of vi-
ral DNA replication, z90% of the genome is expressed
and the amount of RNA made increases up to 10-fold.
During this phase a single MLP is strongly activated and
encodes a large primary transcript that gives rise to five
families of mRNAs (L1–L5) by differential splicing and
polyadenylation (Sharp, 1984). Each of these mRNAs
have in common a 59 noncoding region of 201 nucleotides,
which is called the tripartite leader and is derived by the
splicing of three small introns. Transcription from MLP at-
tains a maximum level at 18 h after infection and then re-
mains constant for at least 10 h, yielding large amounts of
structural polypetides that comprise the virion particle or
are involved in packaging viral genomic DNA. During this
period, the viruses compete with the host cell for control
of the translational apparatus and Ad2 has evolved multi-
ple mechanisms that suppress cellular protein synthesis
and enhance translation of late viral mRNAs. Probably as
a consequence of the block of host protein synthesis, most
coiled bodies disassemble by 16–18 h of viral infection
(Rebelo et al., 1996). However, coiled bodies are present
during the early stages of Ad2 infection and it remained an
open issue whether they are required during that period.
The data presented here indicate that disappearance of
coiled bodies does not impair either early or late phases of
adenoviral infection. In fact, cells that were infected as
long as 24 h after microinjection of mAbs contain high
amounts of spliced tripartite leader mRNAs in the cyto-
plasm and express normal levels of late phase proteins.
In another set of experiments we analyzed the effect of
antibody-induced disassembly of coiled bodies on splicing
of transiently overexpressed b-globin transcripts. Control
experiments show that within 16 h after plasmid injection
there is an intense cytoplasmic hybridization signal pro-
duced by a splice junction probe, indicating that these cells
are splicing large amounts of b-globin pre-mRNAs. Re-
markably, cells that were injected with mAb-d, incubated
for 24 h, and then reinjected with b-globin expression vec-
tor continue to splice and export b-globin mRNA to the
cytoplasm. Thus, highly abundant pre-mRNAs continue to
be spliced in the absence of coiled bodies. However, due
to the long half-lives of spliceosomal snRNPs, it is possible
that during the time course of our experiments the level of
preexisting snRNPs available in the nucleus does not drop
below the threshold required to maintain splicing activity.
Although the data presented here do not exclude the
hypothesis that coiled bodies play a basic role in snRNP
biogenesis or recycling, alternative ideas should be consid-
ered concerning the function of this structure. First, theAlmeida et al. Microinjection of Anti-coilin Antibodies 911
coiled body may simply represent a storage site for sn-
RNPs in the nucleus. However, we find this hypothesis un-
likely taking into account that coiled bodies are very dy-
namic structures strictly dependent upon ongoing RNA
and protein synthesis (Carmo-Fonseca et al., 1992; Lafarga
et al., 1994; Rebelo et al., 1996). Second, coiled bodies may
be involved in some type of protein or snRNA modifica-
tion that is not essential for splicing. For instance, it is
known that snRNAs undergo extensive posttranscrip-
tional modifications on base and sugar residues, and it was
recently proposed that these modifications could be intro-
duced into snRNA at the coiled body, by the same (or sim-
ilar) enzymatic machinery that is used in the nucleolus to
modify rRNA (Bohmann et al., 1995b). Very little is
known about the functional significance of these modifica-
tions in the U1, U2, U5, and U4/U6 snRNPs, and there-
fore it is conceivable that at least some may not be essen-
tial for spliceosome assembly. Third, coiled bodies may be
preferentially involved in the metabolism of specialized
RNAs in differentiated tissue cells such as neurons. Fi-
nally, it is important to consider that coiled bodies, like nu-
cleoli, may represent the morphological consequence of an
activity that does not necessarily require a dedicated com-
partment in the nucleus. In fact, one may argue that the
nucleolus as an organized preassembled structure is not
essential for ribosome biogenesis, since processing of ribo-
somal RNA occurs normally when expressed from a plas-
mid containing a single copy of the rRNA gene (Nierras et
al., 1997). Here we observe that upon disassembly of the
coiled body by antibody injection, the pool of coilin dis-
persed throughout the nucleoplasm is intensified (refer to
Fig. 4). Thus, it is possible that whatever activity is taking
place at the coiled body it may also occur in association
with nucleoplasmic coilin. Consistent with this view, it was
recently reported that coiled bodies tend to associate pref-
erentially with tandem repeated or tightly clustered genes,
suggesting that, like nucleoli and rRNA genes, the coiled
body may arise as a local concentration of p80–coilin de-
termined by expression of these clustered genes (Gao et
al., 1997). In conclusion, it will be important for future ex-
periments addressing the function of the coiled body to fo-
cus on suppressing the expression of p80–coilin at both cell
and organism level.
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